

Search
You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "Jon Leibowitz."
12 result(s) displayed (1 - 12 of 15)
Justices side with FTC's effort to limit states' exemption from antitrust law. Continue reading
Posted on February 20, 2013 1:24 PM
After eight years at the agency and four as its leader, the departing chairman believes 'it's a good time for someone else to take the helm.' Continue reading
Posted on February 15, 2013 10:50 AM
Howard Shelanski is in his second stint at the agency, while Julie Brill and Edith Ramirez round out the current short list. Continue reading
Posted on November 28, 2012 1:39 PM
The pressure to avoid the fiscal cliff will force the White House and Congress to break the policy logjam. Continue reading
Posted on November 9, 2012 4:08 PM
Biglari Holdings agrees to pay $850,000 to settle charges that it violated premerger reporting requirements when it acquired voting securities of Cracker Barrel in 2011. Continue reading
Posted on September 26, 2012 8:56 AM
The Senate has approved seven key nominations affecting dealmakers and their bankers, including filling open seats on the Federal Trade Commission and the board of the Federal Deposit Insurance Corp.The nominations were passed late Thursday as part of a large... Continue reading
Posted on March 30, 2012 12:16 PM
FTC Commissioner Jon Leibowitz discusses his agency's more aggressive stance and what to expect next. Continue reading
Posted on March 9, 2012 12:00 PM
Thomas Rosch said Congress should cut the FTC's budget and give some of its duties to state attorneys general Continue reading
Posted on March 7, 2012 9:56 AM
The attorney who defended Lundbeck in an antitrust case contends that price increases would have happened with or without the company's acquisition of NeoProfen. Continue reading
Posted on February 3, 2012 12:00 PM
A bitter election season is under way, and Washington will become even more stopped up than ever. Nevertheless, expect some real movement on a variety of issues affecting deals. Continue reading
Posted on February 3, 2012 12:00 PM
The FTC tries finally to end Generics' pay-for-delay Deals with branded pharma. But will it survive the healthcare reform? Continue reading
Posted on August 7, 2009 10:10 AM
FTC Chairman Jon Leibowitz has urged Congress to pass controversial legislation amending the antitrust laws to prohibit 'reverse payment' or 'pay for delay' patent settlements between branded and generic pharma companies. Continue reading
Posted on July 24, 2009 2:37 PM
Movable Type search results powered by Fast Search